Enjoy Interactive Tools and Indicators
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
| Brennan Troyen A | EVP, Chief Medical Officer | Apr 15 | Option Exercise | 32.19 | 139,618 | 4,494,299 | 100,834 | Apr 16 04:35 PM |
| Brennan Troyen A | EVP, Chief Medical Officer | Apr 15 | Sale | 57.31 | 139,618 | 8,001,565 | 30,061 | Apr 16 04:35 PM |
| Finucane Anne A. | Director | Apr 15 | Sale | 57.24 | 500 | 28,620 | 11,283 | Apr 16 04:33 PM |
| Brennan Troyen A | EVP, Chief Medical Officer | Mar 19 | Option Exercise | 36.23 | 6,222 | 225,423 | 33,858 | Mar 20 04:20 PM |
| Brennan Troyen A | EVP, Chief Medical Officer | Mar 19 | Sale | 54.00 | 6,222 | 335,988 | 27,636 | Mar 20 04:20 PM |
| Brennan Troyen A | EVP, Chief Medical Officer | Mar 18 | Option Exercise | 36.23 | 28,200 | 1,021,686 | 55,836 | Mar 20 04:20 PM |
| Brennan Troyen A | EVP, Chief Medical Officer | Mar 18 | Sale | 54.00 | 28,200 | 1,522,800 | 27,636 | Mar 20 04:20 PM |
| PICCOLO C A | Director | Dec 14 | Sale | 49.17 | 98,555 | 4,845,646 | 181,461 | Dec 17 04:08 PM |
| Sussman Andrew | SVP & President, MinuteClinic | Oct 04 | Option Exercise | 36.96 | 9,020 | 333,379 | 12,949 | Oct 05 04:09 PM |
| Sussman Andrew | SVP & President, MinuteClinic | Oct 04 | Sale | 49.00 | 9,020 | 441,980 | 3,929 | Oct 05 04:09 PM |
| Bisaccia Lisa | SVP, Chief HR Officer | Oct 01 | Option Exercise | 37.17 | 56,493 | 2,099,789 | 59,640 | Oct 03 03:38 PM |
| Moriarty Thomas M | EVP & General Counsel | Oct 01 | Buy | 48.67 | 6,164 | 300,002 | 6,164 | Oct 03 03:32 PM |
| Bisaccia Lisa | SVP, Chief HR Officer | Oct 01 | Sale | 48.42 | 56,493 | 2,735,407 | 3,147 | Oct 03 03:38 PM |
| Joyner J. David | EVP, Sales & Account Services | Sep 19 | Option Exercise | 20.23 | 33,903 | 685,858 | 55,689 | Sep 21 04:14 PM |
| Joyner J. David | EVP, Sales & Account Services | Sep 19 | Sale | 48.00 | 33,903 | 1,627,344 | 21,786 | Sep 21 04:14 PM |
| Index | S&P 500 | P/E | 18.48 | EPS (ttm) | 3.22 | Insider Own | 0.11% | Shs Outstand | 1.22B | Perf Week | -0.93% |
| Market Cap | 72.86B | Forward P/E | 13.43 | EPS next Y | 4.43 | Insider Trans | 6.31% | Shs Float | 1.22B | Perf Month | 2.41% |
| Income | 4.06B | PEG | 1.35 | EPS next Q | 0.96 | Inst Own | 86.03% | Short Float | 0.95% | Perf Quarter | 15.24% |
| Sales | 123.10B | P/S | 0.59 | EPS this Y | 17.05% | Inst Trans | -0.66% | Short Ratio | 2.04 | Perf Half Y | 33.94% |
| Book/sh | 31.11 | P/B | 1.91 | EPS next Y | 11.31% | ROA | 6.15% | Target Price | 63.82 | Perf Year | 34.64% |
| Cash/sh | 1.27 | P/C | 46.83 | EPS next 5Y | 13.66% | ROE | 10.66% | 52W Range | 42.65 - 60.66 | Perf YTD | 24.11% |
| Dividend | 0.90 | P/FCF | 27.41 | EPS past 5Y | 9.59% | ROI | 7.71% | 52W High | -3.23% | Beta | 0.78 |
| Dividend % | 1.51% | Quick Ratio | 0.69 | Sales past 5Y | 10.11% | Gross Margin | 18.66% | 52W Low | 37.63% | ATR | 0.95 |
| Employees | 203000 | Current Ratio | 1.50 | Sales Q/Q | -0.11% | Oper. Margin | 5.83% | RSI (14) | 53.21 | Volatility | 1.40% 1.52% |
| Optionable | Yes | Debt/Eq | 0.25 | EPS Q/Q | 29.78% | Profit Margin | 3.30% | Rel Volume | 1.05 | Prev Close | 59.51 |
| Shortable | Yes | LT Debt/Eq | 0.24 | Earnings | May 01 BMO | Payout | 21.79% | Avg Volume | 5.70M | Price | 58.70 |
| Recom | 1.90 | SMA20 | 0.19% | SMA50 | 3.57% | SMA200 | 17.48% | Volume | 5,992,581 | Change | -1.36% |
* The data is daily updated on 5:30PM EST